TCTR20160525001已完成2 期
A Randomized Comparison Between Conventional and Costoclavicular Ultrasound-Guided Infraclavicular Blocks
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- one
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 75 Years（—）
- 性别
- All
入选标准
- •- Patients undergoing upper extremity surgery (elbow and below).
- •- American Society of Anesthesiologists classification 1-3
- •- Body mass index between 18 and 30 kg/m2
排除标准
- •- pre existing neuropathy or coagulopathy
- •- renal failure or hepatic failure
- •- allergy to local anesthetics
- •- pregnancy
- •- prior surgery in the area of the infraclavicular fossa
- •- chronic pain syndromes requiring opioid intake at home
研究者
相似试验
进行中（未招募）
1 期
An Efficacy and Safety Study of Alirocumab in Children and Adolescents with Heterozygous Familial HypercholesterolemiaHypercholesterolaemiaMedDRA version: 20.0Level: PTClassification code 10020603Term: HypercholesterolaemiaSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2017-001903-60-DKSanofi-aventis recherche & développement500
进行中（未招募）
1 期
An Efficacy and Safety Study of Alirocumab in Children and Adolescents with Heterozygous Familial HypercholesterolemiaHypercholesterolaemiaMedDRA version: 20.0Level: PTClassification code 10020603Term: HypercholesterolaemiaSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2017-001903-60-HUSanofi-aventis recherche & développement500
进行中（未招募）
1 期
Study to Evaluate the Safety and Efficacy of Crinecerfont in Pediatric Patients With Classic Congenital Adrenal HyperplasiaClassic Congenital Adrenal Hyperplasia (CAH)MedDRA version: 20.0Level: LLTClassification code 10010323Term: Congenital adrenal hyperplasiaSystem Organ Class: 100000004850EUCTR2020-004381-19-ESeurocrine Biosciences, Inc.81
进行中（未招募）
1 期
This is a Study to Evaluate the Safety and Efficacy of ABBV-154 in Subjects with Moderately to Severely Active Rheumatoid Arthritis with Inadequate Response to Biologic and/or Targeted Synthetic Disease-Modifying Anti-Rheumatic Drugs (b/tsDMARDs)Moderate to Severe Rheumatoid ArthritisMedDRA version: 23.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2020-005303-39-GRAbbVie Deutschland GmbH & Co. KG425
进行中（未招募）
不适用
A study to evaluate the effect and safety of a 4 week treatment plan of Alirocumab in patients with high cholesterolPrimary HypercholesterolemiaMedDRA version: 16.1Level: LLTClassification code 10020604Term: HypercholesterolemiaSystem Organ Class: 100000004861EUCTR2013-002343-29-SKRegeneron Pharmaceuticals, Inc.803